BASF Release: Tablets Are More Than Just Active Ingredients

Each year the pharmaceutical industry produces more than 1.3 trillion tablets. These do not only consist of the actual active ingredient, but also of various excipients. They are necessary to ensure that the active ingredient can be absorbed by the body in the right place and at the right time. Depending on requirements they must be formulated and selected. One challenge is the bioavailability. Whereas in the past the active ingredient molecules were often simple and very soluble, they are now often complex and poorly soluble. Thus it is often difficult for the human body to absorb them, which limits their efficacy. More than 70 percent of newly developed active ingredients are affected. In order to improve the bioavailability BASF provides solutions, such as Soluplus®. Overall, the company offers more than 100 different products for the pharmaceutical industry.